PMGC Holdings Inc.
NASDAQ: ELAB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Graydon Bensler
- Employees
- 2
- Headquarters
- Newport Beach, United States
- IPO year
- 2023
- Market cap
- $2.4M
- Website
- https://pmgcholdings.com
Loading ELAB…
Loading profile data…Frequently asked questions about ELAB
What does PMGC Holdings Inc. (ELAB) do?
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing...
Where does ELAB trade?
PMGC Holdings Inc. (ELAB) trades on the NASDAQ Capital Market.
What sector is ELAB in?
PMGC Holdings Inc. (ELAB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PMGC Holdings Inc.?
Graydon Bensler is the chief executive officer of PMGC Holdings Inc. (ELAB).
Where is PMGC Holdings Inc. headquartered?
PMGC Holdings Inc. is headquartered in United States.
Does ELAB pay a dividend?
PMGC Holdings Inc. (ELAB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELAB go public?
PMGC Holdings Inc. (ELAB) completed its initial public offering in 2023.